CorVel Corp (CRVL) - Q3 2026 Filing Summary
Business Context and Reporting Period
This summary covers CorVel Corporation's Form 10-Q for the quarterly period ended December 31, 2025 (Fiscal Q3 2026). CorVel is an independent nationwide provider of medical cost containment and managed care services, primarily serving workers' compensation, automobile insurance, and group health insurance payors. The company operates in a single reportable segment: managed care, which is further divided into Patient Management and Network Solutions service lines.
Key Financial Metrics
| Metric | Q3 2025 (Current) | Q3 2024 (Prior Year) | 9 Months 2025 (YTD) | 9 Months 2024 (YTD) |
|---|---|---|---|---|
| Revenues | $235.6 million | $228.0 million | $710.0 million | $664.1 million |
| Net Income | $24.2 million | $23.8 million | $79.3 million | $68.7 million |
| Diluted EPS | $0.47 | $0.46 | $1.53 | $1.32 |
| Gross Margin | 23.3% | 23.2% | 23.9% | 22.8% |
| Operating Cash Flow (9mo) | $126.2 million (vs. $104.4 million prior YTD) | |||
| Cash & Equivalents | $230.0 million (as of Dec 31, 2025) | |||
| Working Capital | $213.5 million (as of Dec 31, 2025) | |||
| Debt | No long-term debt reported; liabilities consist primarily of accrued liabilities and lease obligations. |
Material Changes vs. Prior Period
- Revenue Growth: Q3 revenue increased 3.4% year-over-year, driven primarily by a 9% increase in Network Solutions services ($89.6M vs. $82.1M). Patient Management services remained relatively flat ($146.1M vs. $145.9M).
- Profitability: Net income rose 1.7% in Q3 and 15.4% on a year-to-date basis. The effective tax rate increased to 25% in Q3 (from 22.8% prior year) due to a decrease in stock option exercises.
- Cost Structure: Cost of revenues increased 3.2% in Q3, tracking with revenue growth. General and administrative expenses increased 2.8%, largely due to increased spending on developed software.
- Share Count: Diluted weighted average shares decreased by 0.9% in Q3 due to the company's ongoing stock repurchase program, which offset the impact of stock option exercises.
Outlook, Risks, and Management Commentary
- Capital Allocation: The company continues its aggressive share repurchase program. In Q3, it repurchased 185,559 shares for approximately $13.4 million. As of December 31, 2025, approximately 2.1 million shares remain available under the program.
- Acquisitions: CorVel acquired a privately held technology firm in Q2 2025 to enhance its bill review process. The company expects to continue evaluating strategic acquisition opportunities.
- Market Conditions: Management notes that while occupational injury counts have not returned to pre-pandemic levels, the company has gained market share. However, they face risks from declining workers' compensation claims, increased competition, and potential legislative changes in state workers' compensation laws.
- Risk Factors: Key risks include cybersecurity threats, reliance on key personnel, potential litigation regarding medical treatment recommendations, and the impact of inflation on labor and benefit costs.
- Liquidity: Management believes cash and cash equivalents ($230M), combined with operating cash flows, are sufficient to meet obligations for the next 12 months and beyond.
Investor Verification Checklist
- Verify the sustainability of the 9% growth in Network Solutions revenue and whether it is driven by price increases or volume.
- Monitor the effective tax rate, which fluctuates based on stock option exercises, to assess true operating profitability.
- Review the impact of the recent technology acquisition on future software development costs and integration expenses.
- Assess the remaining capacity of the stock repurchase program and its impact on future earnings per share.
- Track the trend in workers' compensation claim volumes and the company's ability to offset potential declines with market share gains.